Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart failure with preserved ejection fraction: New approaches to diagnosis and management
Bharathi Upadhya, Dalane W. Kitzman
Clinical Cardiology (2019) Vol. 43, Iss. 2, pp. 145-155
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor
Amr Abdin, Stefan D. Anker, Javed Butler, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 6, pp. 4444-4453
Open Access | Times Cited: 77
Biomarkers in Heart Failure: From Research to Clinical Practice
Alexander Е. Berezin, Alexander A. Berezin
Annals of Laboratory Medicine (2022) Vol. 43, Iss. 3, pp. 225-236
Open Access | Times Cited: 36
Avanços na abordagem terapêutica da insuficiência cardíaca com fração de ejeção preservada (ICFEP): O uso de inibidores de SGLT-2
Francisco de Souza Arnaud Júnior, Renan Daniel De Souza, Rafaella de Abreu Cândido, et al.
Brazilian Journal of Health Review (2023) Vol. 6, Iss. 1, pp. 286-300
Open Access | Times Cited: 20
Diastolic dysfunction in hypertension: a comprehensive review of pathophysiology, diagnosis, and treatment
Camilla Ikast Ottosen, Wilson Nadruz, Riccardo M. Inciardi, et al.
European Heart Journal - Cardiovascular Imaging (2024) Vol. 25, Iss. 11, pp. 1525-1536
Closed Access | Times Cited: 7
Efficacy and safety of semaglutide in patients with heart failure with preserved ejection fraction and obesity
Ayesha Rehman, Shahab Saidullah, Muhammad Asad, et al.
Clinical Cardiology (2024) Vol. 47, Iss. 5
Open Access | Times Cited: 6
Long-term Changes in Body Composition and Exercise Capacity Following Calorie Restriction and Exercise Training in Older Patients with Obesity and Heart Failure With Preserved Ejection Fraction
Bharathi Upadhya, Peter H. Brubaker, Barbara J. Nicklas, et al.
Journal of Cardiac Failure (2024)
Closed Access | Times Cited: 6
Heart failure with preserved ejection fraction based on aging and comorbidities
Ying Lin, Shihui Fu, Yao Yao, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 33
The impact of spiritual care on the psychological health and quality of life of adults with heart failure: a systematic review of randomized trials
Guangwei Zhang, Qiyu Zhang, Fan Li
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
Myocardial contraction fraction predicts outcomes in patients enrolled in the TOPCAT trial
B. Glen Davis, Morris Kim, Yunwoo Burton, et al.
International Journal of Cardiology (2025), pp. 133038-133038
Closed Access
An international modified Delphi consensus study on the optimal diagnosis and treatment of patients with HFpEF
Andrew Sindone, Magdy Abdelhamid, Wael Almahmeed, et al.
Current Medical Research and Opinion (2025), pp. 1-17
Closed Access
Relationship Between Epicardial Adipose Tissue and Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction
Oğuzhan Yücel
Cureus (2025)
Open Access
Heart Failure with Preserved Ejection Fraction in Egypt: An Expert Opinion
Magdy Abdelhamid, Ahmed Salem, Hamza Kabil, et al.
Global Heart (2025) Vol. 20, Iss. 1
Open Access
Development and validation of an integrated prognostic model for all-cause mortality in heart failure: a comprehensive analysis combining clinical, electrocardiographic, and echocardiographic parameters
Yahui Li, Jiayu Xu, Xuhui Liu, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
DRL-ECG-HF: Deep reinforcement learning for enhanced automated diagnosis of heart failure with imbalanced ECG data
Bochao Zhao, Zhenyue Gao, Xiaoli Liu, et al.
Biomedical Signal Processing and Control (2025) Vol. 107, pp. 107680-107680
Closed Access
Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid‐range and preserved ejection fraction
Gijs van Woerden, Dirk J. van Veldhuisen, Thomas M. Gorter, et al.
Clinical Cardiology (2021) Vol. 44, Iss. 7, pp. 987-993
Open Access | Times Cited: 31
SGLT2 inhibitors: an evidence-based update on cardiovascular implications
Imma Forzano, Scott Wilson, Angela Lombardi, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 9, pp. 839-847
Closed Access | Times Cited: 10
Efficacy of sacubitril‐valsartan and SGLT2 inhibitors in heart failure with reduced ejection fraction: A systematic review and meta‐analysis
Xingchun Mo, Ping Lü, Xiaojing Yang
Clinical Cardiology (2023) Vol. 46, Iss. 10, pp. 1137-1145
Open Access | Times Cited: 9
Management of Cardiovascular Disease in the Elderly
Ifeoma Onuorah, Akanksha Agrawal, Nanette K. Wenger
Geriatric medicine (2024), pp. 343-383
Closed Access | Times Cited: 3
A nomogram for predicting the risk of heart failure with preserved ejection fraction
Hua Li, Rong Zhang, Ruichang Chen, et al.
International Journal of Cardiology (2024) Vol. 407, pp. 131973-131973
Closed Access | Times Cited: 3
Quantitative assessment of left ventricular myocardial work in patients with different types of atrial fibrillation by non‐invasive pressure‐strain loop technique
Tingting Liu, Hailan Liu, Yan Song, et al.
Echocardiography (2024) Vol. 41, Iss. 3
Open Access | Times Cited: 3
Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs
Agapios Sachinidis
Cells (2020) Vol. 9, Iss. 4, pp. 1001-1001
Open Access | Times Cited: 26
Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis
Sha Fu, Zhenjian Xu, Baojuan Lin, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 22
Quality of life and disease experience in patients with heart failure with reduced ejection fraction in Spain: a mixed-methods study
Raül Rubio Renau, Beatriz Palacios, Luis Varela, et al.
BMJ Open (2021) Vol. 11, Iss. 12, pp. e053216-e053216
Open Access | Times Cited: 21
Skeletal muscle abnormalities in heart failure with preserved ejection fraction
Matthew J. Anderson, Clifton Forrest Parrott, Mark J. Haykowsky, et al.
Heart Failure Reviews (2022) Vol. 28, Iss. 1, pp. 157-168
Closed Access | Times Cited: 14
Genomic, Proteomic, and Metabolic Comparisons of Small Animal Models of Heart Failure With Preserved Ejection Fraction: A Tale of Mice, Rats, and Cats
Alex Smith, Raffaele Altara, Ghadir Amin, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 15
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top